Desmoid tumor differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
Sara Mohsin (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{S.M.}}{{Faizan}} | {{CMG}} {{AE}}{{S.M.}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
Desmoid tumor must be differentiated from acute hematoma, [[lymphoma]], [[fibrosarcoma]], [[rhabdomyosarcoma]], [[liposarcoma]], [[leiomyosarcoma]], [[neurofibroma]], benign fibrous tumor and [[primitive neuroectodermal tumor]]. | [[Desmoid tumor]] must be differentiated from acute [[hematoma]], [[lymphoma]], [[fibrosarcoma]], [[rhabdomyosarcoma]], [[liposarcoma]], [[leiomyosarcoma]], [[neurofibroma]], [[benign]] [[fibrous]] [[tumor]] and [[primitive neuroectodermal tumor]]. | ||
==Differentiating Desmoid tumor from other Diseases== | ==Differentiating Desmoid tumor from other Diseases== | ||
*'''Extra- | *'''Extra-[[abdominal]] [[fibromatosis]]/[[desmoid tumor]]''' must be differentiated from:<ref name="EconomouPitta2011">{{cite journal|last1=Economou|first1=Athanasios|last2=Pitta|first2=Xanthi|last3=Andreadis|first3=Efstathios|last4=Papapavlou|first4=Leonidas|last5=Chrissidis|first5=Thomas|title=Desmoid tumor of the abdominal wall: a case report|journal=Journal of Medical Case Reports|volume=5|issue=1|year=2011|pages=326|issn=1752-1947|doi=10.1186/1752-1947-5-326}}</ref><ref name="pmid21478276">{{cite journal| author=Kasper B, Ströbel P, Hohenberger P| title=Desmoid tumors: clinical features and treatment options for advanced disease. | journal=Oncologist | year= 2011 | volume= 16 | issue= 5 | pages= 682-93 | pmid=21478276 | doi=10.1634/theoncologist.2010-0281 | pmc=3228186 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21478276 }} </ref><ref name="pmid17711447">{{cite journal| author=Carlson JW, Fletcher CD| title=Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. | journal=Histopathology | year= 2007 | volume= 51 | issue= 4 | pages= 509-14 | pmid=17711447 | doi=10.1111/j.1365-2559.2007.02794.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17711447 }} </ref> | ||
**[[Fibrosarcoma]]/fibroblastic sarcoma | **[[Fibrosarcoma]]/[[fibroblastic sarcoma]] | ||
**Low-grade fibromyxoid sarcoma<ref name="pmid19152188">{{cite journal| author=Wu X, Petrovic V, Torode IP, Chow CW| title=Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance. | journal=Pathology | year= 2009 | volume= 41 | issue= 2 | pages= 155-60 | pmid=19152188 | doi=10.1080/00313020802579276 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19152188 }} </ref><ref name="pmid20471519">{{cite journal| author=Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N et al.| title=Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma. | journal=Cancer Genet Cytogenet | year= 2010 | volume= 199 | issue= 2 | pages= 143-6 | pmid=20471519 | doi=10.1016/j.cancergencyto.2010.02.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20471519 }} </ref> | **Low-grade fibromyxoid [[sarcoma]]<ref name="pmid19152188">{{cite journal| author=Wu X, Petrovic V, Torode IP, Chow CW| title=Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance. | journal=Pathology | year= 2009 | volume= 41 | issue= 2 | pages= 155-60 | pmid=19152188 | doi=10.1080/00313020802579276 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19152188 }} </ref><ref name="pmid20471519">{{cite journal| author=Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N et al.| title=Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma. | journal=Cancer Genet Cytogenet | year= 2010 | volume= 199 | issue= 2 | pages= 143-6 | pmid=20471519 | doi=10.1016/j.cancergencyto.2010.02.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20471519 }} </ref> | ||
**Gardner fibroma<ref name="pmid11342777">{{cite journal| author=Wehrli BM, Weiss SW, Yandow S, Coffin CM| title=Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. | journal=Am J Surg Pathol | year= 2001 | volume= 25 | issue= 5 | pages= 645-51 | pmid=11342777 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11342777 }} </ref> | **Gardner [[fibroma]]<ref name="pmid11342777">{{cite journal| author=Wehrli BM, Weiss SW, Yandow S, Coffin CM| title=Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. | journal=Am J Surg Pathol | year= 2001 | volume= 25 | issue= 5 | pages= 645-51 | pmid=11342777 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11342777 }} </ref> | ||
*'''Intra- | *'''Intra-[[abdominal]] [[fibromatosis]]''' must be differentiated from:<ref name="pmid17414097">{{cite journal| author=Coffin CM, Hornick JL, Fletcher CD| title=Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. | journal=Am J Surg Pathol | year= 2007 | volume= 31 | issue= 4 | pages= 509-20 | pmid=17414097 | doi=10.1097/01.pas.0000213393.57322.c7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17414097 }} </ref> | ||
**Gastrointestinal stromal tumor (GIST) | **[[Gastrointestinal stromal tumor]] (GIST) | ||
**Solitary fibrous tumor (SFT) | **Solitary fibrous tumor (SFT) | ||
**Inflammatory myofibroblastic tumor (IMT) | **[[Inflammatory]] myofibroblastic [[tumor]] (IMT) | ||
**Sclerosing mesenteritis | **Sclerosing mesenteritis | ||
**Retroperitoneal fibrosis due to:<ref name="pmid19515472">{{cite journal| author=Swartz RD| title=Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. | journal=Am J Kidney Dis | year= 2009 | volume= 54 | issue= 3 | pages= 546-53 | pmid=19515472 | doi=10.1053/j.ajkd.2009.04.019 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19515472 }} </ref> | **[[Retroperitoneal fibrosis]] due to:<ref name="pmid19515472">{{cite journal| author=Swartz RD| title=Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. | journal=Am J Kidney Dis | year= 2009 | volume= 54 | issue= 3 | pages= 546-53 | pmid=19515472 | doi=10.1053/j.ajkd.2009.04.019 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19515472 }} </ref> | ||
***Idiopathic [Ormond's disease] | ***[[Idiopathic]] [<nowiki/>[[Ormond's disease]]] | ||
***Secondary to certain drugs | ***[[Secondary]] to certain [[drugs]] | ||
***Underlying malignancy such as lymphoma | ***Underlying [[malignancy]] such as [[lymphoma]] | ||
*Furthermore, desmoid | *Furthermore, [[desmoid tumor]]<nowiki/>s must be differentiated from: | ||
**Acute hematoma | **Acute [[hematoma]] | ||
**[[Lymphoma]] | **[[Lymphoma]] | ||
**[[Rhabdomyosarcoma]] | **[[Rhabdomyosarcoma]] | ||
| Line 26: | Line 26: | ||
**[[Leiomyosarcoma]] | **[[Leiomyosarcoma]] | ||
**[[Neurofibroma]] | **[[Neurofibroma]] | ||
**Nodular fasciitis | **[[Nodular fasciitis]] | ||
**Hypertrophic scars | **[[Hypertrophic scars]] | ||
**Keloids | **[[Keloids]] | ||
**Benign fibrous tumor | **[[Benign]] fibrous [[tumor]] | ||
**[[Primitive neuroectodermal tumor]] | **[[Primitive neuroectodermal tumor]] | ||
Revision as of 14:32, 6 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Faizan Sheraz, M.D. [3]
Overview
Desmoid tumor must be differentiated from acute hematoma, lymphoma, fibrosarcoma, rhabdomyosarcoma, liposarcoma, leiomyosarcoma, neurofibroma, benign fibrous tumor and primitive neuroectodermal tumor.
Differentiating Desmoid tumor from other Diseases
- Extra-abdominal fibromatosis/desmoid tumor must be differentiated from:[1][2][3]
- Fibrosarcoma/fibroblastic sarcoma
- Low-grade fibromyxoid sarcoma[4][5]
- Gardner fibroma[6]
- Intra-abdominal fibromatosis must be differentiated from:[7]
- Gastrointestinal stromal tumor (GIST)
- Solitary fibrous tumor (SFT)
- Inflammatory myofibroblastic tumor (IMT)
- Sclerosing mesenteritis
- Retroperitoneal fibrosis due to:[8]
- Idiopathic [Ormond's disease]
- Secondary to certain drugs
- Underlying malignancy such as lymphoma
- Furthermore, desmoid tumors must be differentiated from:
Reference
- ↑ Economou, Athanasios; Pitta, Xanthi; Andreadis, Efstathios; Papapavlou, Leonidas; Chrissidis, Thomas (2011). "Desmoid tumor of the abdominal wall: a case report". Journal of Medical Case Reports. 5 (1): 326. doi:10.1186/1752-1947-5-326. ISSN 1752-1947.
- ↑ Kasper B, Ströbel P, Hohenberger P (2011). "Desmoid tumors: clinical features and treatment options for advanced disease". Oncologist. 16 (5): 682–93. doi:10.1634/theoncologist.2010-0281. PMC 3228186. PMID 21478276.
- ↑ Carlson JW, Fletcher CD (2007). "Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature". Histopathology. 51 (4): 509–14. doi:10.1111/j.1365-2559.2007.02794.x. PMID 17711447.
- ↑ Wu X, Petrovic V, Torode IP, Chow CW (2009). "Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance". Pathology. 41 (2): 155–60. doi:10.1080/00313020802579276. PMID 19152188.
- ↑ Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N; et al. (2010). "Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma". Cancer Genet Cytogenet. 199 (2): 143–6. doi:10.1016/j.cancergencyto.2010.02.011. PMID 20471519.
- ↑ Wehrli BM, Weiss SW, Yandow S, Coffin CM (2001). "Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis". Am J Surg Pathol. 25 (5): 645–51. PMID 11342777.
- ↑ Coffin CM, Hornick JL, Fletcher CD (2007). "Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases". Am J Surg Pathol. 31 (4): 509–20. doi:10.1097/01.pas.0000213393.57322.c7. PMID 17414097.
- ↑ Swartz RD (2009). "Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment". Am J Kidney Dis. 54 (3): 546–53. doi:10.1053/j.ajkd.2009.04.019. PMID 19515472.